SBI Life Insurance Company Limited
SBILIFE.NS
₹1780.10
▼ 0.02%
SBI Life Insurance was essentially flat, down a negligible 0.02%, after shares had slipped recently on margin compression that offset otherwise strong growth in the June quarter. Profit after tax rose 22% to Rs 720-725 crore and annualized premium equivalent surged 36% to Rs 5,380 crore, but the value of new business margin narrowed to 26.2% from 27.4% even as VNB itself grew 29% to Rs 1,410 crore. Solvency remained steady at 1.96, and Motilal Oswal maintained its Buy rating with a revised target of Rs 2,240. The broader analyst pool of 36 carries a "strong buy" consensus with an average target of Rs 2,342.97, well above the current price of Rs 1,780.10.
CAGR Performance
| 1 Year | 2 Years | 5 Years | 10 Years |
|---|---|---|---|
| -4.12% | 0.59% | 9.62% | 10.96% |
Analyst Consensus
Average Target Price: ₹2342.97 (range ₹1050.00 - ₹2790.00) based on 36 analysts
Strong Buy: 5
Buy: 29
Hold: 1
Sell: 0
Strong Sell: 0
Related News
| Jul 24, 2026 | SBI Life Insurance Q1 PAT 7.25 Billion Rupees |
No comments:
Post a Comment